1,602 hedge funds and large institutions have $108B invested in Amgen in 2017 Q3 according to their latest regulatory filings, with 93 funds opening new positions, 611 increasing their positions, 643 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

0.54% more ownership

Funds ownership: 78.5%79.03% (+0.54%)

5% less call options, than puts

Call options by funds: $1.3B | Put options by funds: $1.36B

5% less repeat investments, than reductions

Existing positions increased: 611 | Existing positions reduced: 643

Holders
1,602
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
88
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.3B
Puts
$1.36B
Net Calls
Net Calls Change

Top Buyers

1 +$380M
2 +$260M
3 +$259M
4
Goldman Sachs
Goldman Sachs
New York
+$185M
5
PI
Putnam Investments
Massachusetts
+$158M

Top Sellers

1 -$394M
2 -$236M
3 -$206M
4
Flossbach Von Storch
Flossbach Von Storch
Germany
-$181M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$162M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$308M
52
$306M
53
$304M
54
$304M
55
$301M
56
$290M
57
$287M
58
$283M
59
$273M
60
$265M
61
$254M
62
$246M
63
$240M
64
$238M
65
$238M
66
$235M
67
$234M
68
$224M
69
$219M
70
$216M
71
$204M
72
$199M
73
$190M
74
$188M
75
$181M